Hereditary angioedema in cardiac surgery: Perioperative management considerations for a rare disease

Perfusion. 2024 Jul;39(5):1017-1019. doi: 10.1177/02676591231174773. Epub 2023 May 8.

Abstract

Introduction: Hereditary Angioedema is a rare disease caused by C1 esterase inhibitor deficiency leading to diffuse and potentially life-threatening oedema formation. Preventing attacks is critical, particularly for patients undergoing cardiac surgery.

Case report: We report a case of a 71-years-old woman with a history of Hereditary Angioedema scheduled for open-heart surgery on Cardiopulmonary Bypass. Multidisciplinar teamwork and patient-targeted strategy were crucial to obtain a favorable outcome.

Discussion: Cardiac surgery is a major stressor for Angioedema attacks because of Complement cascade and inflammatory response activation leading to potential life-threatening oedema formation. In literature only few cases of complex open heart surgery under Cardiopulmonary Bypass are described.

Conclusion: Continuous updating and multidisciplinarity are key elements to manage patients with Hereditary Angioedema in cardiac surgery in order to reduce morbidity and mortality.

Keywords: C1 esterase inhibitor deficiency; cardiac surgery; cardiopulmonary bypass; hereditary angioedema; perioperative management.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angioedemas, Hereditary* / complications
  • Cardiac Surgical Procedures / adverse effects
  • Cardiac Surgical Procedures / methods
  • Cardiopulmonary Bypass / adverse effects
  • Cardiopulmonary Bypass / methods
  • Female
  • Humans
  • Perioperative Care* / methods
  • Rare Diseases